Table 2.

Comparison of the laryngeal cancer frequency before and after COVID-19 pandemic

	Before COVID-19 pandemic (n:57)	After COVID-19 pandemic (n:40)	p Value
Gender
Female	3 (5.3%)	3 (7.5%)	0.48
Male	54 (94.7%)	37 (92.5%)
Age (years)
Mean ± SD	62.8 ± 6.5	57.3 ± 6.8	< 0.001
Glottic	35 (61.4%)	22 (55%)	0.52
Subglottic	9 (15.8%)	8 (20%)	0.59
Supraglottic	23 (40.4%)	24 (60%)	0.06
Transglottic	12 (21.1%)	14 (35%)	0.12
Pre-epiglottic	20 (35.1%)	18 (45%)	0.32
Anterior commissure	35 (61.4%)	22 (55%)	0.52
Subglottic extension	9 (15.8%)	8 (20%)	0.59
Thyroid	11 (19.3%)	12 (30%)	0.22
Cricoid	1 (1.8%)	3 (7.5%)	0.18
T0	26 (45.6%)	11 (27.5%)	0.07
T1	13 (22.8%)	8 (20%)	0.74
T2	6 (10.5%)	3 (7.5%)	0.44
T3	1 (1.8%)	1 (2.5%)	0.65
T4	4 (7%)	12 (30%)	0.003
N0	47 (82.5%)	26 (65%)	0.06
N1	2 (3.5%)	0 (0)	0.34
N2a	3 (5.3%)	5 (12.5%)	0.18
N2b	3 (5.3%)	5 (12.5%)	0.18
N2c	1 (1.8%)	3 (7.5%)	0.18

Bold values depicts p < 0.05